PGNX Overview
Upcoming Projects (PGNX)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (PGNX)
-
Don’t see a project related to the company you care about? Create your own!
Expired Projects (PGNX)
-
Digging into Progenics’ PyL Imaging Agent for Prostate Cancer after its Phase ⅔ data release at AUA May 6, 2019
Ticker: PGNX
Execute By: May 13, 2019
Upcoming & Overdue Catalysts (PGNX)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (PGNX)
-
Progenics (PGNX) Expects Data in Q1 2017 from Phase 2b Pivotal Trial of Azedra in Pheochromocytoma
Ticker: PGNX
Occurred on: Mar 30, 2017 -
Progenics (PGNX) Phase 2 Results Evaluating SPECT/CT Agent 1404 Published in Journal of Nuclear Medicine
Ticker: PGNX
Occurred on: Mar 24, 2017 -
PDUFA April 19 2016 of Oral RELISTOR for treatment of opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain
Tickers: PGNX, VRX
Occurred on: Jul 19, 2016 -
Progenics Projected to Complete Enrollment of Phase 3 of PSMA Targeted Imaging Agent 1404 for Prostate Cancer in Early in 2016
Ticker: PGNX
Occurred on: Jan 07, 2016
Strategic Initiatives (PGNX)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
